etomoxir has been researched along with Disease Exacerbation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, DC; Baisgaard, AE; Bolther, L; Hald, JL; Huijbers, IJ; Huntjens, P; Kroese, LJ; Kullab, UB; Mørk, K; Nieland, JDV; Oklinski, KE; Pritchard, CEJ; Trabjerg, MS; Warming, N | 1 |
| Rupp, H | 1 |
| Rupp, H; Vetter, R | 1 |
3 other study(ies) available for etomoxir and Disease Exacerbation
| Article | Year |
|---|---|
Downregulating carnitine palmitoyl transferase 1 affects disease progression in the SOD1 G93A mouse model of ALS.
Topics: Amyotrophic Lateral Sclerosis; Animals; Carnitine O-Palmitoyltransferase; Disease Models, Animal; Disease Progression; Down-Regulation; Enzyme Inhibitors; Epoxy Compounds; Female; Gastrointestinal Microbiome; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutation; Superoxide Dismutase-1 | 2021 |
Drug development based on functional genomics of overloaded cardiomyocytes: a novel approach for preventing progression of heart failure.
Topics: Animals; Calcium-Transporting ATPases; Disease Progression; Drug Design; Epoxy Compounds; Heart Failure; Humans; Myocytes, Cardiac; Rats; Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2004 |
Sarcoplasmic reticulum function and carnitine palmitoyltransferase-1 inhibition during progression of heart failure.
Topics: Animals; Aortic Valve Stenosis; Body Weight; Calcium; Calcium-Transporting ATPases; Carnitine O-Palmitoyltransferase; Disease Progression; Enzyme Inhibitors; Epoxy Compounds; Heart Failure; Heart Ventricles; Hypertrophy; Isoenzymes; Myosins; Organ Size; Rats; Rats, Wistar; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Time Factors | 2000 |